February 6, 2024 — The cardiothoracic surgery program at Englewood Health has achieved a three-star rating from The Society of Thoracic Surgeons (STS) for isolated coronary artery bypass graft (CABG) surgery.
In its 2023 public report, STS reported that less than 20 percent of participating programs nationwide received a 3-star rating. Englewood Health is among just six programs in New Jersey to achieve the highest quality rating.
The recently published data covers CABG cases from July 2020 through June 2023. In addition to the 3-star composite score, the team achieved a near perfect score (99.76) for medication use. Englewood Health performed better than the STS average score in all CABG Composite Quality Rating categories.
“We extend our congratulations to our dedicated team of cardiothoracic surgeons and practitioners, whose remarkable expertise and collaborative efforts consistently achieve the best possible outcomes for our patients,” said Adam Arnofsky, MD, chief of cardiothoracic surgery at Englewood Health. “Englewood Health’s cardiothoracic surgery team is at the forefront of healthcare, employing cutting-edge technologies and advanced surgical techniques to enhance and safeguard the lives of individuals facing heart disease.”
The STS National Database is the premier cardiothoracic surgery clinical outcomes registry. The STS helps hospitals and CT surgeons assess and benchmark their performance to improve quality, safety, and patient outcomes. Englewood Health voluntarily submits CABG surgery clinical data to the STS. The STS calculates performance scores and star ratings for isolated CABG using 3-year analytic data windows.